Skip to main content

Juan Fernando Fuentes Cabrera

I'm a doctor specializing in Otorhinolaryngology and Head and Neck Surgery. Within the ENT department , I work in the head and neck section, with special interest in head and neck cancer and minimally invasive techniques such as robotic surgery, as well as benign pathology in this area. I have a special interest in teaching, and I am a tutor for residents in Otorhinolaryngology training.

Institutions of which they are part

Head and Neck Cancer: Biomedical Research Cancer Stem cells
Vall Hebron Institut de Recerca
Ear, Nose and Throat
General Hospital
Juan Fernando Fuentes Cabrera

Juan Fernando Fuentes Cabrera

Juan Fernando Fuentes Cabrera

Institutions of which they are part

Head and Neck Cancer: Biomedical Research Cancer Stem cells
Vall Hebron Institut de Recerca
Ear, Nose and Throat
General Hospital

I'm a doctor specializing in Otorhinolaryngology and Head and Neck Surgery. Within the ENT department , I work in the head and neck section, with special interest in head and neck cancer and minimally invasive techniques such as robotic surgery, as well as benign pathology in this area. I have a special interest in teaching, and I am a tutor for residents in Otorhinolaryngology training.

I graduated as an MD at Universidad Francisco Marroquín and completed my specialization via MIR in Otorhinolaryngology at the Hospital Universitario Vall d'Hebron (2010-2014).

Since 2016 I joined the Otorhinolaryngology and Head and Neck Surgery Service at Vall d'Hebron.

Within the service I'm specialized in head and neck surgery and oncology. I have been part of the robotic head and neck surgery team since its formation and I'm certified as a robotic surgeon.


In addition, I'm a referent doctor for the Adult Tracheostomy Patient Care Unit and the patient safety referent for ENT.

Associate professor of otorhinolaryngology at the Autonomous University of Barcelona for the degrees of Medicine and Speech Therapist.

I participate in biomedical research with cancer stem cells at the Vall Hebron Research Institute.

Projects

Establecimiento de una estrategia combinada en carcinoma escamoso de cabeza y cuello (HNSCC): una herramienta eficaz para superar los tumores quimiorresistentes.

IP: Matilde Lleonart Pajarin
Collaborators: Yoelsis Garcia Mayea, Juan Lorente Guerrero, Josep Castellví Vives, Marina Bataller Fernández, Pablo Sanchez Sancho, Almudena Sanchez Garcia, Juan Fernando Fuentes Cabrera, Juan Fernando Fuentes Cabrera
Funding agency: Instituto de Salud Carlos III
Funding: 240000
Reference: PI24/00630
Duration: 01/01/2025 - 31/12/2027

NANORESCAN

IP: Matilde Lleonart Pajarin
Collaborators: David Virós Porcuna, Josep Castellví Vives, Marina Bataller Fernández, Almudena Sanchez Garcia, Juan Fernando Fuentes Cabrera, Juan Fernando Fuentes Cabrera
Funding agency: Instituto de Salud Carlos III
Funding: 318750
Reference:  AC24/00057
Duration: 01/01/2025 - 31/12/2027

Related news

The sessions were aimed at establishing new collaborations to advance the prevention and treatment of this type of tumour.

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

The Biomedical Research in Cancer Stem Cells group at VHIR has identified a new therapeutic target and is working to find new therapies for this type of tumor.

Related professionals

Mercedes Olalla Garrido Martín

Mercedes Olalla Garrido Martín

Multidisciplinary Nursing Research Group
Read more
Judith Sacanell Lacasa

Judith Sacanell Lacasa

Shock, Organ Dysfunction and Resuscitation
Read more
Meritxell Ibernon Vilaró

Meritxell Ibernon Vilaró

Kidney Physiopathology
Read more
Imanol Otaegui Irurueta

Imanol Otaegui Irurueta

Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.